Table 1.

Cancer vaccines in Phase III completed based on tumor-associated antigens (TAAs).

Tumor	Peptide Vaccine	Status	Phases	NCT Number	Ref.
Breast Cancer	Nelipepimut-S (NP-S)	Completed	Phase 3	NCT01479244	[39]
Metastatic Melanoma	MDX-1379 (gp100)	Completed	Phase 3	NCT00094653	[40]
	gp100	Completed	Phase 3	NCT00019682	[41]
Multiple Myeloma	MAGE-A3/NY-ESO-1	Completed	Phase 2/Phase 3	NCT00090493	N.A.
Esophageal Cancer/Gastric Cancer	G17DT	Completed	Phase 3	NCT00020787	N.A.